Lebendnierentransplantation – Wie ist der Ablauf?

Weltweit hat sich die Lebendnierenspende zu einem Standardverfahren in der Transplantationsmedizin entwickelt und so die Wartezeiten der Organempfänger verkürzt. Da eine Lebendnierenspende kurz- und langfristige Risiken birgt, ist es von wesentlicher Bedeutung, dass der potenzielle Spender von organischer, aber auch von psychosozialer Seite genau untersucht wird. Dabei muss der Spender auch über versicherungsrechtliche Probleme aufgeklärt werden. In Zukunft müssen die langfristige Nachsorge der Spender sowie versicherungsrechtliche Aspekte noch mehr in den Mittelpunkt der Bemühungen um eine optimierte Lebendnierenspende rücken.

Living kidney transplantation is routinely performed for more than 20 years. It is well-known that the recipients benefit from living kidneys, whereas the donor carries some risks on the short and long run. Because of this, the evaluation of the donor must be done very carefully, including not only medical and psychological examinations. Long-term follow-up and aspects of local insurance systems must be included, too, in order to optimize the care for the living donor.

Key words

living kidney donation - recipients - donors - evaluation - follow-up - insurance systems

• Literatur

• 1 Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336
• 2 Opelz G. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation 1997; 64: 1473-1475
• 3 UNOS Ethics Committee. Ethics of organ transplantation from living donors. Transplant Proc 1992; 24: 2236-2237
• 4 DSO (Deutsche Stiftung Organtransplantation). Zahlen 2011;
• 5 Kasiske BL, Ravenscraft M, Ramos EL et al. The evaluation of living renal transplant donors: clinical practice guidelines. Ad hoc clinical practice guidelines subcommittee of the patient care and education committee of the American society of Transplant Physicians. J Am Soc Nephrol 1996; 7: 2288-2313
• 6 Switzer GE, Dew MA, Twillman RK. Psychosocial issues in living organ donation. In: Trzepacz PT, DiMartini AF, eds. The transplant patient: biological, psychiatric and ethical issues in organ transplantation. New York (NY): Cambridge University Press; 2000: 42-66
• 7 Garg AX, Muirhead N, Knoll G et al. Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801-1810
• 8 Prasad GV, Shukla A, Huang M et al. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006; 82: 1130-1135
• 9 § 8 Deutsches Transplantationsgesetz (TPG).
• 10 Klein K, Süsal C, Schäfer SM et al. Living donor kidney transplantation in patients with donor-specific HLA-antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Atheroscler Suppl 2013; 14: 199-202
• 11 Delmonico F. A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005; 79 (Suppl. 01)
• 12 Delmonico FL, Dew MA. Living donor kidney transplantation in a global environment. Kidney Int 2007; 71: 608-614
• 13 Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006; 6: 2535-2542
• 14 Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic APOL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
• 15 Zargooshi J. Quality of life of Iranian kidney „donors“. J Urol 2001; 166: 1790-1799
• 16 Clemens KK, Thiessen-Philbrook H, Parikh CR et al. Donor Nephrectomy Outcomes Research (DONOR) Network. Psychosocial health of living kidney donors: a systematic review. Am J Transplant 2006; 6: 2965-2977